Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "edwards lifesciences"

Edwards Lifesciences Beats Q4 Earnings, Raises '16 View
Zacks.com

Edwards Lifesciences Corp to Post Q1 2016 Earnings of $0.65 Pe...

Edwards Lifesciences Corp (NYSE:EW) Stock analysts at William Blair upped their Q1 2016 earnings per share (EPS) estimates for Edwards Lifesciences Corp in a research note issued on Tuesday, Zacks Investment Research reports. William Blair analyst ... SleekMoney, 21 hours ago
[x]  

28 images for edwards lifesciences

News 9, 2 days ago
Yahoo! Singapore, 2 days ago
MassDevice, 1 day ago
Investor's Business Daily, 1 week ago
Zacks.com, 1 day ago
Nasdaq, 4 days ago
Medical Design Online, 2 days ago
Nasdaq, 1 day ago
Nasdaq, 2 days ago
Solonews.net, 3 days ago

Top Funds Heart Edwards Lifesciences, Bump Lilly

Market volatility revved into high gear in January, making investors queasy from all the ups and downs. Stocks ended up a bust in the first month of the year on the backs of the oil slump and weak corporate earnings. The Nasdaq plunged 7.9% in ...
 Investor's Business Daily1 day ago

Buy Edwards Lifesciences After Pullback - Cramer's Lightning Round (2/4/16)

MGM Resorts International over Las Vegas Sands. Sirius XM's business is good. Stay away from Apollo Education. Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Thursday, February 4. Bullish Calls Las Vegas ...
 Seeking Alpha1 day ago 'Mad Money' Lightning Round: I'm Buying Sirius XM Radio  TheStreet.com1 day ago 'Mad Money' Lightning Round: Buy Cypress Semiconductor, Avoid Covanta  TheStreet.com1 week ago
Medical Design Online

Edwards CEO Touts Increased Adoption of TAVR Program

By Jof Enriquez Follow me on Twitter @jofenriq Edwards Lifesciences reported a strong fourth quarter performance built on increased adoption of transcatheter-based heart valve therapies, and company CEO Michael A. Mussallem believes momentum ...
 Medical Design Online2 days ago Edwards Lifesciences Announces $325 Million Accelerated Share Repurchase  ADVFN UK2 days ago Edwards Lifesciences TAVR sales increase 25 percent in fourth quarter  Cardiovascular Business2 days ago Edwards Lifesciences (EW) Michael A. Mussallem on Q4 2015 Results - Earnings Call Transcript  Seeking Alpha4 days ago
[x]  

New Lifetime High For Edwards Lifesciences (EW)

Trade-Ideas LLC identified Edwards Lifesciences ( EW) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified Edwards Lifesciences as such a stock due to the following factors: EW has an average ...
 TheStreet.com2 days ago Edwards Lifesciences (EW) Showing Signs Of Being A Momo Momentum Stock  TheStreet.com3 days ago Edwards Lifesciences (EW) Showing Resistance Near $81.61  PredictWallStreet1 week ago Edwards Lifesciences (EW) On Momo Momentum Watch Today  TheStreet.com2 weeks ago

Edwards Lifesciences boosts full-year profit outlook

Feb 2 Edwards Lifesciences Corp raised its full-year earnings forecast on Tuesday, anticipating stronger sales of its artificial heart valves implanted in a minimally invasive procedure that spares patients from open-chest surgery. Fourth-quarter ...
 Reuters4 days ago Edwards lifts outlook as heart valve sales accelerate  Reuters4 days ago UPDATE 1-Edwards Lifesciences boosts full-year profit outlook  MyInforms4 days ago UPDATE 2-Edwards lifts outlook as heart valve sales accelerate  Reuters UK4 days ago
[x]  
MassDevice

Edwards Lifesciences to accelerate share buybacks

Edwards Lifesciences (NYSE: EW ) enters into an accelerated share repurchase (ASR) agreement with Morgan Stanley to buy back $325M of its common stock. The deal is part of its previously authorized $750M repurchase program. The company has agreed ...
 Seeking Alpha2 days ago Edwards Lifesciences accelerates buyback with $350m share repurchase  MyInforms1 day ago

BRIEF-Edwards Lifesciences Q4 GAAP earnings per share $0.64

Feb 2 Edwards Lifesciences Corp : * Q4 net sales $671.1 million versus $618 million last year * Q4 GAAP earnings per share $0.64 * Q4 non-GAAP earnings per share $0.63 * Q4 Transcatheter Heart Valve therapy (THV) sales $334.3 million, up 25 ...
 Reuters4 days ago

Edwards Lifesciences +4.7% on Q4 beats, raised guidance

Edwards Lifesciences ( EW -2.5%) is up 4.7% after hours following a Q4 beat on top and bottom lines where global transcatheter heart valve therapy sales were up 25%. Non-GAAP EPS grew 18.9%. U.S. segment sales were $353.6M; international sales ...
 Seeking Alpha4 days ago

Edwards Lifesciences beats by $0.01, beats on revenue

Edwards Lifesciences (NYSE:EW): Q4 EPS of $0.63 beats by $0.01. Revenue of $671.1M (+8.6% Y/Y) beats
 Seeking Alpha4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - edwards lifesciences
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less